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Peroxidation of cardiolipin in mitochondria is essential for the execution of apoptosis. We suggested
that integration of oleic acid into cardiolipin generates non-oxidizable cardiolipin species hence
protects cells against apoptosis. We synthesized mitochondria-targeted triphenylphosphonium
oleic acid ester. Using lipidomics analysis we found that pretreatment of mouse embryonic cells
with triphenylphosphonium oleic acid ester resulted in decreased contents of polyunsaturated
cardiolipins and elevation of its species containing oleic acid residues. This caused suppression of
apoptosis induced by actinomycin D. Triacsin C, an inhibitor of acyl-CoA synthase, blocked integra-
tion of oleic acid into cardiolipin and restored cell sensitivity to apoptosis.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Cardiolipin (CL) is a mitochondria-speciﬁc doubly charged anio-
nic phospholipid with four fatty acid residues [1]. In normal cells, it
is exclusively localized to the innermitochondrialmembrane (IMM)
where it accounts for25%of all phospholipids [2]. CL is synthesized
on the matrix side of the IMM [3,4] as a premature form that is
deacylated by phospholipases A to generate monolyso-CL [5–7].chemical Societies. Published by E
ne; IMM, innermitochondrial
CL acyltransferase; ER, endo-
nsferase-1; ACSL, long chain
ynthase; TPP, triphenylphos-
lphosphoniumoctadecaenoic
liquid chromatography-mass
noic acid; C22:6, docosahexa-
ee Radical and Antioxidant
tional Health, University of
ite 350, Pittsburgh, PA 15219,
an@pitt.edu (V.E. Kagan).The latter can be re-acylated by tafazzin, a mitochondrial phospho-
lipid trans-acylase [6,8] predominantly present in the IMM [9], to
yield mature species of CL [10]. In addition, mitochondria contain
a coenzyme A-(CoA)-dependent acyltransferase, mono-lyso-CL
acyltransferase (MLCL AT), that acylates monolyso-CL to CL [11]. Fi-
nally, endoplasmic reticulum (ER) acyl-CoA lyso-CL acyltransferase-
1 (ALCAT 1), known to be upregulated by oxidative stress [12,13],
can also catalyze synthesis of polyunsaturated CL species [14].
In addition to CL’s multiple structural and signaling functions in
normal cell physiology, it is also an important player in apoptotic
cell death pathways. Changes of the CL content and oxidation
status have been associated with the execution of extrinsic and
intrinsic apoptosis [15,16]. The early stage of intrinsic apoptosis
is characterized by the formation of CL/cytochrome c (cyt c) com-
plexes in mitochondria that exhibit a potent peroxidase activity to-
wards polyunsaturated CL [17]. Polyunsaturated species of CL have
been identiﬁed as a preferred oxidation substrate of cyt c catalyzed
reactions in vitro [18,19] and in vivo [20–23]. Accumulation of CL
oxidation products in mitochondria of apoptotic cells has been
found essential for the release of pro-apoptotic factors into the
cytosol [17]. We suggested that integration of mono-unsaturatedlsevier B.V. All rights reserved.
236 Y.Y. Tyurina et al. / FEBS Letters 586 (2012) 235–241oleic acid residues into mitochondrial CL – via its remodeling path-
ways in mitochondria – will generate non-oxidizable CL species
thus protecting cells against apoptosis. We synthesized a poorly-
peroxidizable triphenylphosphonium (TPP) octadecaenoic acid
(C18:1) ester (TPP-C18:1) and used it for targeted delivery into
mitochondria of mouse embryonic cells (MEC). Using liquid chro-
matography/mass spectrometry (LC/MS) based lipidomics analysis
we established that pro-apoptotic stimulation with actinomycin D
(AcD) was accompanied by selective oxidative consumption of CL
molecular species containing polyunsaturated octadecadienoic
(C18:2), eicosatetraenoic (C20:4), and docosahexaenoic (C22:6)
acids. Pretreatment of MEC with TPP-C18:1 resulted in: (i) signiﬁ-
cant decrease of CL polyunsaturated molecular species and simul-
taneous elevation of poorly-oxidizable CL molecular species
containing C18:1 and (ii) suppression of AcD induced apoptosis.
An inhibitor of long chain acyl-CoA synthase (ACSL), triacsin C,0
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Fig. 1. Apoptosis and CL oxidation induced by AcD in MEC. (A) Apoptosis induced by AcD
(100 ng/ml). Data are means ± S.E., n = 10, ⁄P < 0.05 vs control. (B) AcD-induced oxidation
LC/MS quantitative assessment of oxidizable (b) and oxidized (c) CL molecular species. C
detected and shown on inserts. (d) Base peak chromatogram of CL molecular species
oxygenated CL molecular species ((C18:2)3(C18:2-OH), retention time 12.2 min) was detecblocked integration of C18:1 into CL molecules and restored MEC’s
sensitivity to AcD-induced apoptosis.
2. Methods
2.1. Synthesis of TPP-C18:1
3-[(Z)-octadec-9-enoyl]oxypropyl-triphenyl-phosphonium
chloride: A suspension of C18:1 (1 mmol) and silver nitrate
(2 mmol) was stirred at 25 C for 2 h. (3-bromopropyl)triphenyl-
phosphonium bromide (1 mmol) was added and the reaction mix-
ture was further stirred at 25 C for 12 h. Thereafter, the mixture
was ﬁltered and the ﬁltrate evaporated to dryness under reduced
pressure. The remaining residue was re-dissolved in 50% methanol
containing 1% NaHCO3 and 1% NaCl. The TPP ester was extracted
with ethyl acetate and the extract dried over Na2SO4. Evaporationm/z 1448 m/z 1472 m/z 1494 m/z 1496
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9-enoyl]oxypropyl-triphenyl-phosphonium chloride (ESI-MS anal-
ysis revealed a single peak with m/z = 585.4).
2.2. Cell culture
Mouse embryonic cells (MEC) were grown in Dulbecco’s Modi-
ﬁed Eagle Medium containing 15% fetal bovine serum, 25 mM
HEPES, 0.05 mg/ml uridine, 0.05 mM 2-mercaptoethanol, 1
MEM (Invitrogen, Carlsbad, CA) and 100 U/ml penicillin/strepto-
mycin in a humidiﬁed atmosphere (5% CO2 plus 95% air). Cells were
pretreated with TPP-C18:1 (1–50 lM) at 37 C for 2 h and after that
exposed to AcD (100 ng/ml) at 37 C for 16 h. To block ASCL cells
were treated with triacsin C (10 lM) at 37 C for 30 min. Cell via-
bility was measured using AlamarBlue assay (Invitrogen, Carlsbad,
CA). Apoptosis was evaluated by phosphatidylserine (PS) external-
ization using Annexin V–FITC apoptosis detection kit (Biovision,
Mountain View, CA) and caspase 3/7 with a luminescence Cas-
pase–Glo™ 3/7 assay kit (Promega, Madison, WI).
2.3. Analysis of CL
Lipids were extracted using the Folch procedure [24]. Lipid
phosphorus was determined by a micro-method [25]. LC/MS was
performed using a Dionex Ultimate™ 3000 HPLC coupled on-line
to a linear ion trap mass spectrometer (LXQ Thermo-Fisher) as
described [21]. CL was separated by 2D-HPTLC [26] and fatty acids
were analyzed by LC/MS after hydrolysis of CL with porcine pan-
creatic phospholipase A2 (PLA2) as described [21].
2.4. Analysis of TPP-C18:1
Mitochondria were isolated from MEC treated with TPP-C18:1
(50 lM, for 2 h at 37 C) as described [27]. TPP-C18:1 was extracted
from mitochondria by Folch procedure [24] and LC/MS in positive
modewas performed using a Dionex Ultimate™3000 HPLC coupled
on-line to a linear ion trapmass spectrometer (LXQ Thermo-Fisher).
TPP-C18:1 and TPP were separated on a normal phase column (Luna
3 lm Silica 100A, 150  2 mm, (Phenomenex, Torrance CA)) with
ﬂow rate 0.2 mL/min using gradient solvents containing 5 mM
CH3COONH4 (A – n-hexane:2-propanol:water, 43:57:1 (v/v/v) and
B – n-hexane:2-propanol:water, 43:57:10 (v/v/v). At these condi-
tions the retention times for TPP-C18:1 and TPP were 27.9 and
50.6 min, respectively.
2.5. Statistics
The results are presented as mean ± S.E.M. values from at least
three experiments, and statistical analyses were performed by
either paired/unpaired Student’s t-test or one-way ANOVA. The
statistical signiﬁcance of differences was set at P < 0.05.0
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Fig. 2. LC/MS analysis of TPP-C18:1 and its hydrolysis product, TPP, in mitochondria
of MEC. (A) LC/MS base peak proﬁles of TPP-C18:1 and TPP in mitochondria fromMEC
exposed to TPP-C18:1. (B) Quantitative assessment of TPP-C18:1 and TPP in
mitochondria. Data are means ± S.E. n = 6.3. Results
3.1. AcD-induced apoptosis and oxidative consumption of CL in MEC
To avoid complications possibly associated with non-speciﬁc
oxidative events commonly accompanying the execution of apop-
totic program triggered by redox-cycling agents (e.g., paraquat, tet-
racyclines antibiotics, quinones) as well as sources of oxidizing
equivalents like H2O2 we used a known non-oxidant inducer of
mitochondria-dependent intrinsic cell death pathway, AcD [28].
Accordingly, AcD induced apoptosis in MEC as evidenced by cas-
pase 3/7 activation (Fig. 1Aa) and PS externalization (Fig. 1Ab).
To assess the role of CL peroxidation in AcD-induced apoptosiswe employed LC/MS analysis of CL molecular species. In a typical
negative mode MS spectrum of CL from MECs, six clusters were
detectable (Fig. 1Ba). Thirty six molecular species of CLs contained
oxidizable polyunsaturated fatty acid residues [19]. We found a
signiﬁcant decrease in the amount of polyunsaturated CLs in cells
challenged with AcD (vs control cells) – in line with likely peroxi-
dative ‘‘consumption’’ of polyunsaturated molecular species of CL.
The oxidation was selective: signiﬁcant decreases of the contents
occurred only in four molecular species of CL – with m/z 1448,
m/z 1472, m/z 1494 and m/z 1496 – containing C18:2, C20:4, and
C22:6 fatty acid residues and corresponding to (C18:2)4, (C18:2)3
(C20:4), (C18:2)2(C20:4)2 and (C18:2)3(C22:6), respectively (Fig. 1Bb).
Quantitative assessment of oxidized CL revealed accumulation of
oxidation products formed from these CL molecular species
(Fig. 1Bc,d) that were represented by species containing 1–4 oxy-
gens in their fatty acid residues (Fig. 1Bc, inserts).
3.2. Effect of TPP-C18:1 on AcD-induced apoptosis and CL oxidation in
MEC
We reasoned that delivery of TPP-conjugated monounsaturated
C18:1 into mitochondria would favor its integration into CL through
acyl-CoA-dependent remodeling pathways by MLCL AT or ALCAT 1
[6,12,13]. Using an uncoupler might be diagnostic of potential-dri-
ven accumulation of TPP-C18:1 in mitochondria. However, experi-
ments with uncouplers in cells are complicated by their cytotoxic
effects. A recent study discovered another intricacy in interactions
of TPP-based penetrating ions with anions of fatty acids that can
act as mitochondria-targeted protonophorous uncouplers [29].
238 Y.Y. Tyurina et al. / FEBS Letters 586 (2012) 235–241Therefore, we chose to employ LC/MS to assess the content of
TPP-C18:1 and its de-esteriﬁed product, TPP, in mitochondria of cells
exposed to TPP-C18:1. Direct LC/MS analysis demonstrated the pres-
ence of TPP-C18:1 and its hydrolysis product, TPP in mitochondria of
treated cells (Fig. 2A). Quantitative assessment revealed that the
amount of TPP-C18:1 and TPP was 83.0 ± 5.2 and 41.0 ± 4.5 nmol/
mg mitochondrial protein, respectively (Fig. 2B). Given that
accumulation of TPP-conjugated non-modiﬁed and modiﬁed
fatty acids such as dodecyl-TPP, TPP-imidazole-substituted C18:0
and C18:1 in mitochondria has been demonstrated in previous
studies [27,29] – it is conceivable, although still hypothetic, that
TPP-C18:1 employed in the present work also accumulated in
mitochondria.
Interestingly, LC/MS analysis of lipids in TPP-C18:1 treated MEC
revealed signiﬁcant decrease in the levels of exactly those CL-
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to AcD. At the same time, the content of C18:1-containing species
of CL, particularly CL-(C18:1)4 (m/z 1456) was markedly increased
(Fig. 3Aab). In line with this, LC/MS analysis of fatty acids after
CL hydrolysis by PLA2 demonstrated the increase of C18:1
(Fig. 3Ac) and decrease of C18:2, C20:4, C20:3, C22:6 and C22:5 fatty acid
residues in CL molecules (Fig. 3Ad).
Assuming that CL peroxidation is essential for the execution of
the mitochondrial segment of apoptotic program, TPP-C18:1 should
exert anti-apoptotic effect. Indeed, treatment with TPP-C18:1 mark-
edly increased resistance of MEC to AcD induced apoptosis as
evidenced by inhibition of PS externalization (Fig. 3Ba) and caspase
3/7 activity (Fig. 3Bb). In contrast, C18:1 without the TPP-moiety did
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Y.Y. Tyurina et al. / FEBS Letters 586 (2012) 235–241 239apoptosis in these cells (data not shown). Importantly, the AcD-
induced ‘‘oxidative consumption’’ of polyunsaturated CL molecular
species was signiﬁcantly less pronounced in cells pre-treated with
TPP-C18:1 (Fig. 4A). These results indicate that selective CL remod-
eling leading to the accumulation of its non-peroxidizable species
is associated with the protection of cells against AcD-induced
apoptosis.
3.3. Effect of triacsin C on AcD-induced apoptosis and CL oxidation in
TPP-C18:1 treated MEC
To further verify that CL remodeling is responsible for anti-apop-
totic effect of TPP-C18:1, we utilized triacsin C – an inhibitor of ACSL,
an enzyme that generates acyl-CoAs [30]. We found that triacsin C
treated cells exhibited high sensitivity to AcD-induced apoptosisA
B a
aC
Fig. 4. Effect of triascin C on apoptosis and CL oxidation induced by AcD in MEC treated w
are presented as increase of oxidized CL molecular species. Data are means ± S.E., n =
phopsphatidylserine expernalization (a) and caspase 3/7 activation (b) in MEC. Data are
triacsin C treated (a) and triacsin C treated TPP-C18:1 exposed cells (b). The amounts of CL
as 33.3 ± 1.9, 13.8 ± 2.0, 9.6 ± 1.8 and 6.5 ± 1.6 pmol/nmol of total CL in triacsin C pre-trea
pre-treated/TPP-C18:1 exposed cells, respectively. Consequently, the amount of CL molecu
means ± S.E., n = 3–5.and abolished the anti-apoptotic effect of TPP-C18:1 (Fig. 4B).
Neither signiﬁcant enrichment of CL with C18:1 (Fig. 4Cab) nor
changes in CL oxidation (Fig. 4A) were detected in triacsin C
treated/TPP- C18:1 exposed cells compared to control. Thus, CL
re-acylation pathway – dependent on ACSL-driven formation of
acyl-CoA – is the likely major contributor to the anti-apoptotic ef-
fect of TPP-C18:1 in MEC.
4. Discussion
MEC are commonly used as a normal cell culturemodel for stud-
ies of cell death pathways including apoptosis [31–33]. It has been
demonstrated that MEC exhibit typical apoptotic features such as
DNA fragmentation, PS externalization, caspase 3/7 activation as
well as cyt c release in response to different stimuli including AcDb
b
ith TPP-C18:1. (A) Effect of AcD, TPP-C18:1 and triacsin C on CL oxidation in MEC. Data
3–7, ⁄P < 0.05 vs control. (B) Effect of TPP-C18:1 and triacsin C on AcD-induced
means ± S.E., n = 3–10, ⁄P < 0.05 vs control. (C) Content of CL molecular species in
molecular species withm/z 1448,m/z 1472,m/z 1494 andm/z 1496 were estimated
ted and 37.6 ± 3.9, 11.0 ± 3.1, 6.6 ± 4.3 and 3.9 ± 3.1 pmol/nmol of total CL in triacsin
lar species withm/z 1456 was 16.4 ± 3.4 to 24.7 ± 4.2 pmol/nmol of total CL. Data are
240 Y.Y. Tyurina et al. / FEBS Letters 586 (2012) 235–241[17,19,34]. Because the goal of this work was to develop protective
strategies against apoptosis, we chose to employ amodel of normal,
rather than tumor, cells for the current study.
Accumulation of CL oxidation products – predominantly CL-
hydroperoxides – is a required early stage of apoptosis essential
for the release of pro-apoptotic factors – including cyt c – from
mitochondria into the cytosol [17]. This was uniformly characteris-
tic of different pro-apoptotic stimuli in cultured cells in vitro
[18,19] and several types of exposures in vivo such as total body
irradiation [21,22], hyperoxia [20] and traumatic brain injury
[23]. This CL and its peroxidation may act as a mitochondrial
switch regulating sensitivity of cells to apoptosis [17] hence repre-
sent a new target for drug discovery. The peroxidation process is
catalyzed by an intermembrane space protein of mitochondria –
cyt c – that forms a high afﬁnity peroxidase complex with polyun-
saturated CLs [17]. Inhibitors of the peroxidase activity effective in
suppressing CL peroxidation have been shown to exert potent anti-
apoptotic effects [19,20,35]. Among those, mitochondria-targeted
imidazole-substituted fatty acids displayed a potent anti-apoptotic
effect in vitro and in vivo resulting in signiﬁcant protection against
acute radiation damage [27].
This work demonstrates, for the ﬁrst time, that mitochondrial
delivery of poorly peroxidizale mono-unsaturated TPP-C18:1
resulted in remodeling of endogenous pool of CLs such that CLs
containing polyunsaturated fatty acid residues becomes less abun-
dant while the content of C18:1-containing species increased. This
remodeling conferred increased resistance of MEC to AcD induced
apoptosis. Given that saturated fatty acid residues do not undergo
peroxidative modiﬁcations, they may represent an alternative
group of compounds for CL remodeling with potential anti-apopto-
tic consequences. However, it has been reported that saturated
fatty acids are poor substrates for CL reacylation reactions [13]
and the rates of their turnover in CLs are very low [36].
The diversity of CLs is deﬁned by twomajor metabolic pathways
– its biosynthesis and remodeling. De novo synthesis via condensa-
tion of one molecule of phosphatidylglycerol and one molecule of
cytidine-50-diphosphate-1,2-diacylglycerol catalyzed by CL syn-
thase (CLS1) takes place in mitochondria [3,4]. It is believed that
de novo synthesis is responsible for non-speciﬁc diversiﬁcation of
CL molecular species while acyl-speciﬁc remodeling limits and
ﬁne-tunes the number of CL molecular species in different tissues
[37]. At least three enzymes are involved in remodeling of CL. Tafaz-
zin, a mitochondrial phospholipid transacylase – presents exclu-
sively in the IMM [6,8,9] – transfers acyl residues, predominantly
linoleic acid, from PC and PE into monolyso-CL [38–40] indepen-
dently of CoA [41]. CoA-dependent remodeling of CLs can occur in
both mitochondria and ER [12,13]. It is catalyzed by MLCL AT and
ALCAT 1 with high speciﬁcity towards poly- and monounsaturated
fatty acids [13]. Both enzymes utilize acyl-CoA as a substrate in the
reaction for acylation of mono-lyso-CL [11,13] and can be speciﬁ-
cally down regulated through inhibition of ACSL by triascin C
[30]. In linewith this, our results demonstrated that triascin C effec-
tively inhibited TPP-C18:1-driven remodeling of CL in MEC. Notably,
triascin C also restored sensitivity of TPP-C18:1-supplemented cells
to AcD-induced apoptosis suggesting that CoA-dependent remodel-
ing is involved in modiﬁcation of CL in MEC exposed to TPP-C18:1..
This is further supported by our oxidative lipidomics measure-
ments which revealed that only four out of thirty six polyunsatu-
rated molecular species of CL were selectively oxidized in MEC
during apoptosis triggered by AcD. By metabolically manipulating
these CL species and decreasing their susceptibility to peroxidation
we were be able to decrease the sensitivity of cells to apoptosis.
Our previous work established that by suppressing CLS1 by spe-
ciﬁc RNAi we were able to cause CL-deﬁciency, decrease CL peroxi-
dation thus increase resistance of HeLa cells challenged with AcD
to apoptosis [28]. Here, we experimentally tested an alternativeapproach based on manipulations of CL oxidizability using poorly-
oxidizable C18:1. To minimize C18:1 toxicity and deliver C18:1 into
cells and mitochondria without damaging them, we conjugated
C18:1with anorganic cationTPP– commonlyused for deliverydiffer-
ent payloads into mitochondria via ‘‘electrophoretic mechanism’’
based on negative inside mitochondrial membrane potential
[42–44]. TPP conjugated fatty acids can be rapidly hydrolyzed intra-
cellularly by esterases in mitochondria and ER [27]. Therefore, une-
steriﬁed C18:1 can be quickly activated byACSL that present in the ER
ormitochondria [45,46] to C18:1-CoA and utilized for CL remodeling.
It is possible that enrichment of mitochondria with oleoyl-con-
taining CLmolecular speciesmay affect interactions of this essential
anionic phospholipidwith a number of mitochondrial proteins such
as cyt c oxidase [47,48], creatine kinase [49,50], ATP synthase
[51,52] mitochondrial ADP carrier [53] resulting in altered func-
tional status.Ourpreviouswork, however, demonstrated thatdeple-
tion of 55%of endogenousCL inHeLa cells did not affect their growth
rate, mitochondria biomarker proteins and levels of ATP and mito-
chondrial membrane potential [28]. Further, cyt c binding constant
for tetra-oleoyl-CL was similar to that of tetra-linoleoyl-CL [54].
In summary,we developed a newapproach to regulate cell’s sen-
sitivity to apoptosis via manipulations of their CL’s oxidizability.
While our ﬁndings on regulation of sensitivity to apoptosis via
manipulations of the CL’s oxidizability have been obtained using
MEC as a normal cell culture model, we suggest that this approach
may be applicable to other cell types as well. Indeed, oxygenation
of CLmolecular speciesduringapoptosis of differentnormalprimary
cell cultures, including lung epithelial cells, lung endothelial cells,
rat cortical neurons has been reported [18,20,21]. However, meta-
bolic remodeling of CLs can be utilized as an effective tool not only
for suppressing (by non-oxidizable fatty acid precursors) but also
for enhancing (via highly oxidizable polyunsaturated fatty acid pre-
cursors) apoptotic death pathway. In this way, this approach can be
utilized for the development of new therapeutic modalities to
prevent excessive apoptosis or stimulate it in cancer cells.
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